Vertex Pharmaceuticals’ second quarter 2025 results exceeded Wall Street’s expectations, but the market responded sharply ...

SentientLight ( has announced a capital development plan beginning with an initial tranche of approximately US$2 million toward a targeted US$10 million raise. Once secured, these funds will support: ...